SBRT	Stereotactic body radiation therapy
HCC	Hepatocellular carcinoma
NTCP	Normal tissue complication probability
RILD	Radiation induced liver disease
MRI	Magnetic resonance imaging
CP	Child-Pugh
ALBI	Albumin-Bilirubin
MELD	Model for end-stage liver disease
QUANTEC	Quantitative analysis of normal tissue effects in the clinic
ICG	Indocyanine green
ICG-R15	ICG retention at 15 min after injection
CT	Computed tomography
DCE-CT	Dynamic contrast-enhanced computed tomography
DECT	Dual energy CT
SPECT	Single-proton emission computed tomography
SC	Sulphur colloid
HIDA	Hepatobiliary iminodiacetic acid
GSA	Galactosyl human serum albumin
FLV	Functional liver volume
LSR	Liver-to-spleen uptake ratio
TLF	Total liver function
ASGPR	Asialoglycoprotein receptor
LUV	Liver uptake value
FLI	Functional liver index
PET	Positron emission tomography
FDGal	Fluoro-D-galactose
T2w	T2-weighted
IP	In-phase
OP	Opposed phase
T1w	T1-weighted
DWI	Diffusion-weighted imaging
DCE-MRI	Dynamic contrast-enhanced MRI
GTV	Gross tumour volume
OAR	Organs at risk
ADC	Apparent diffusion coefficient
IVIM	Intra-voxel incoherent motion
DKI	Diffusion kurtosis imaging
AUC	Area under the curve
MTT	Mean transit time
HEF	Hepatic extraction fraction
MRE	Magnetic resonance elastography
ASL	Arterial spin labeling
NID	Normalised iodine density
RECIST	Response evaluation criteria in solid tumours
mRECIST	modified RECIST
EASL	European association of study of the liver
LI-RADS	Liver imaging reporting and data system
FLR	Focal liver reaction
EQD2	Equivalent dose in 2 Gy fractions
BED	Biologically effective dose
PRISM	Personalised liver stereotactic body radiation therapy using magnetic resonance imaging